CAS No.: | 174641-44-2 |
---|---|
Formula: | C74h132n26o27 |
Type: | Lyophilized Powder |
Appearance: | Powder |
Quality: | Pharmaceutical Grade |
Colour: | White |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
HEP-1 (Human Ezrin Peptide) is a tetradecapeptide synthetic immunomodulator with a molecular weight of 1818 Da and consisting of 14 amino acid residues: Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu (= TEKKRRETVEREKE).
Application: HIV, hepatitis, STIs, herpes types 1 and 2, genital herpes, rabies, purulent infection, alcohol intoxication, salpingo-oophoritis, endometritis, lupus erythematosus, wound healing.
The peptide HEP-1 was developed by Dr. Rupert Donald Holms in the UK and patented in 1994 as a drug for the prevention and treatment of acquired immunodeficiency syndrome (AIDS), systemic lupus erythematosus (SLE) and related diseases. Later HEP-1 was patented in the USA, Russia and other countries.
Structural formula:Welcome to be our distinguished customer, please do not hesitate to contact us!
# | Product | Sequence | Therapeutic Area | Form | Unit Size |
4109712 | Semaglutide CAS No.: 910463-68-2 |
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | Type II diabetes mellitus Obesity |
Lyophilized powder | 2 mg/vial 5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial 1 g/tube |
4109713 | Tirzepatide CAS No.: 2023788-19-2 |
H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Type II diabetes mellitus Obesity |
Lyophilized powder | 10 mg/vial 15 mg/vial 20 mg/vial 30 mg/vial 60 mg/vial 1 g/tube |
4109714 | Cagrilintide CAS No.: 1415456-99-3 |
{Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 | Type II diabetes mellitus Obesity |
Lyophilized powder | 5 mg/vial 10 mg/vial 1 g/tube |
4109715 | CagriSema | Blend | Type II diabetes mellitus Obesity |
Lyophilized powder | 5 mg/vial 10 mg/vial 20 mg/vial 1 g/tube |
4109716 | Retatrutide CAS No. 2381089-83-2 |
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Treatment of type 2 diabetes Treatment of obesity |
Lyophilized powder | 8 mg 10 mg 12 mg 15 mg 1 g/tube |
Suppliers with verified business licenses